LENGTH OF STAY AND COST DUE TO RECURRENT CLOSTRIDIUM DIFFICILE INFECTIONS (CDI) AT A UNIVERSITY HOSPITAL IN FINLAND
Author(s)
Agthe N1, Mattila E2, Purmonen T1, Kanerva M21Oy Medfiles Ltd, Kuopio, Finland, 2Helsinki University Hospital, Helsinki, Finland
Presentation Documents
OBJECTIVES: The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) has highlighted recurrence as the most important problem in the management of CDI. There is lack of knowledge regarding length of stay (LOS) and cost associated with recurrent clostridium difficileinfection (CDI). Our objective was to collect real life data for estimating days of hospitalization and costs attributable to recurrent CDI. METHODS: A prospective observational study was conducted at Helsinki University Central hospital during February 2007 and May 2008. The CDI patients were identified from the microbiology laboratory reports to one of the six acute wards included in the study. Only healthcare associated CDI cases were included. The recurrence of CDI was defined as a new positive sample less than eight weeks after the first one. The patients had no previous history of CDI one month prior to first positive sample. Resource use data were extracted from the medical records using Appropriateness Evaluation Protocol-based methodology. Unit costs were obtained from literature, hospital administration, laboratory and pharmacy. RESULTS: During the 16 months study period, 72 CDI patients were identified, which corresponds to incidence of 0.7-3.8/1,000 patient days. Of those, 7 % were recurrent cases (5 patients). Mean LOS for recurrent cases was 3.17 times longer than among non-recurrent cases. The mean incremental cost for recurrent CDI was €6,800 which was 2.52 times higher than the average incremental cost of the total CDI population (€2,700, and €2,300 for not recurrent cases). Most of the resource use came from additional treatment days (94% of total cost). Other costs were due to laboratory tests, medication and isolation. CONCLUSIONS: Recurrent CDI is associated with significantly longer LOS and higher costs compared to the average CDI population. The main cost driver between the groups was length of stay
Conference/Value in Health Info
2012-11, ISPOR Europe 2012, Berlin, Germany
Value in Health, Vol. 15, No. 7 (November 2012)
Code
PIN29
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Infectious Disease (non-vaccine)